Monitoring Antioxidant/Redox Status at Concordia (MARS-C)

Oxidative Stress Clinical Trial

— MARS-C  

Official title:

Monitoring Antioxidant/Redox Status and Replenishing Nitrogen & Sulfur-based Nutrients to Enhance Resilience at Concordia (MARS-C): Understanding Integrated Stress Signalling

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT04197193
• Other study ID #: 49348
• Status: Active, not recruiting
• Start date: October 3, 2022
• Est. completion date: December 2024

Study information

• Verified date: January 2024
• Source: University of Southampton
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The European Space Agency (ESA) runs a research centre in Antarctica as an earth-based model for long duration deep-space missions. Just like astronauts travelling into space, crew-members overwintering at this Concordia base are exposed to a number of extreme environmental stressors; including high altitude (approximately 3800m); extreme cold; long periods of 24 hour darkness or daylight; and complete isolation. The investigators will recruit up to 30 over-wintering crew members working at this station for ESA over a 2 year period and observe how their bodies adapt and respond to the stress of living and working in this environment. The investigators will collect blood, saliva and urine samples, together with ultrasound images of muscle mass and grip strength measurements at regular intervals throughout their deployment to Antarctica. These samples will be transported back to Southampton to be analysed for biochemical levels of stress. During the final month of their stay, all participants will be randomised to receive a daily nutritional drink which is either high or low in targeted dietary supplements. Following similar studies that the investigators has successfully performed over shorter durations at high altitudes previously, they hypothesise that levels of stress experienced in extreme environments such as Antarctica or deep space can be reduced with targeted nutritional supplementation. These findings may become important to members of the general public as commercial aviation moves increasingly towards using low space-orbital vehicles to drastically reduce international travel times over the coming decade.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 30
• Est. completion date: December 2024
• Est. primary completion date: December 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Adult

• Member of Concordia station over-wintering crew

• Able to give written informed consent

• Fluent in either English, French or Italian

Exclusion Criteria:

• Participating in another interventional research study during the deployment to Concordia

Related Conditions & MeSH terms

• Oxidative Stress

Locations

Country	Name	City	State
United Kingdom	University of Southampton	Southampton

Sponsors (2)

Lead Sponsor	Collaborator
University of Southampton	European Space Agency

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Hand grip strength	Forearm muscle / grip strength recorded non-invasively using a hand grip dynamometer	up to 10 months
Secondary	Muscle mass	cross sectional forearm muscle area recorded a standardised way using medical ultrasound	up to 10 months
Secondary	Oxidative stress	Nitrate, nitrite, nitroso species, FRAP, TFTs, glutathione ratios, 8-isoprostane,	up to 10 months
Secondary	Lake Louise Score 2018	A validated measure of altitude related symptoms and illness which scores symptoms across 4 different domains: headache, GI disturbance, fatigue & dizziness. Each is scored from 0 - 3 (for no symptoms to very debilitating respectively) and a total score of 3 or more including at headache symptoms is required for a positive diagnosis of Acute Mountain Sickness	up to 10 months